Press release
“Safe Routes to School” Funding Encourages Children to Walk and Bicycle to School
Safe Routes to School (SRTS) works to create safer routes for walking and bicycling to school. SRTS promotes increasing physical activity among children, pedestrian safety, minimizing traffic congestion, helping the environment and building connections between families, schools and the community.In 2005, Congress approved $612 million to establish Safe Routes to School (SRTS) funding in all 50 states and the District of Columbia. Each State Department of Transportation (DOT) received a minimum of $1 million per fiscal year through 2009 for SRTS efforts. Congress extended the program to $183 million per year starting in 2010 until a long-term transportation reauthorization is complete.
Each state is required to allocate between 70-90% of the SRTS funds for infrastructure projects (sidewalks, bike lanes, trails, intersection improvements, etc.), and between 10-30% for non-infrastructure activities (programs that relate to education, encouragement and enforcement).
SA-SO is happy to say that we are able to provide you with your infrastructure project needs. We carry products such as: ADA sidewalk tile, school zone signage, bike racks, crosswalk safety gear, custom signs and much more. All of these products are approved and meet the requirements for SRTS infrastructure projects.
Each State DOT has developed (or is in the process of developing) their own methods to distribute the SRTS funds. As such, there is considerable variation from state to state, and each state is in charge of its own program. To get in touch with your State Safe Routes to School Program Coordinator and to learn more about SRTS funding for your state visit: www.saferoutesinfo.org.
SA-SO offers a wide variety of facility, traffic and safety products. SA-SO specializes in making signs to meet customer’s exact specifications. Contact SA-SO at 972-641-4911 or check out their website at: www.sa-so.com.
SA-SO is your one stop for all your Facility, Traffic and Safety products. Our specialty at SA-SO is manufacturing custom street signs, traffic signs and whiteboards. All customization is done "in-house" guaranteeing a fast turnaround time for our customers.
Company Name: SA-SO
Hayley Wells, Marketing Director
Ph. No. 972-641-9411
Address: 930 W. North Carrier Parkway,Grand Prairie,TX, 75050
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release “Safe Routes to School” Funding Encourages Children to Walk and Bicycle to School here
News-ID: 150244 • Views: …
More Releases for SRTS
Lysosomal Storage Disease Treatment Market Valuation, ROI Potential & Long-Term …
The lysosomal storage disease (LSD) treatment market is entering a dynamic phase of innovation and commercialization as advances in molecular diagnostics, enzyme technologies, and gene therapies broaden therapeutic options for a set of rare, genetically driven disorders. LSDs including Gaucher disease, Fabry disease, Pompe disease, and mucopolysaccharidoses (MPS) collectively affect tens of thousands of patients worldwide. Historically underserved due to small patient populations and complex biology, this therapeutic area is…
Gaucher's Disease Market to Reach USD 2.41 Billion by 2034
Pune, India - December 2025 - The global Gaucher's Disease Market, valued at USD 1.42 billion in 2024, is projected to reach USD 2.41 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing diagnosis of lysosomal storage disorders (LSDs), expanding access to enzyme replacement therapies (ERT), and advancements in substrate reduction and gene therapy approaches are driving steady market growth.
Download Full PDF Sample Copy of…
Gaucher Disease Treatment Market Advances on Diagnostic Uptake and Late-Stage In …
The Global Gaucher Disease Treatment Market is set for steady growth through 2031, driven by rising diagnosis rates, expanding access to enzyme replacement therapy, and late-stage innovations targeting neuronopathic forms, with notable momentum from pipeline assets such as venglustat, PR001, and FLT201 in key regions including the US, EU4/UK, Japan, and LATAM.
Executive summary
The market for Gaucher disease treatments is advancing at a measured pace as improved awareness, expanded screening, and…
Niemann-Pick Disease Type C (NPC) Market is expected to reach USD 2.8 billion by …
Niemann-Pick Disease Type C (NPC) is a rare, progressive, and life-threatening lysosomal storage disorder caused by mutations in the NPC1 or NPC2 genes. The disease impairs cholesterol and lipid metabolism within cells, leading to severe neurological dysfunction, hepatosplenomegaly, and premature death. Affecting approximately 1 in 100,000 to 150,000 live births worldwide, NPC is often referred to as "childhood Alzheimer's" due to its devastating impact on cognition and motor skills.
Download Full…
Gaucher Disease Treatment Market 2025-2032: Top Trends & Growth Drivers | Genzym …
Gaucher Disease Treatment Market encompasses therapies designed to manage and treat Gaucher disease, a rare genetic lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase. The primary products in this space include enzyme replacement therapies (ERTs) and substrate reduction therapies (SRTs), which help reduce lipid accumulation in cells and improve organ function. ERTs, such as imiglucerase and velaglucerase alfa, offer proven efficacy and a favorable safety profile, leading…
Gaucher's Disease Treatment Market Size 2032 | Sanofi, Genzyme, Orphazyme, Avro …
As per DelveInsight's assessment, the Gaucher Disease market size in the 7MM is anticipated to increase in the coming years owing to the rising prevalent population of Gaucher Disease patients in the 7MM countries. The launch of the upcoming therapies will also fuel market growth. DelveInsight's "Gaucher's Disease Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as…